Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | CDK1 | P06493 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11522523 | 0.94 | HTT (0.40) | HTTCDK1CA12CA1CA2 | |
| SCHEMBL11381319 | 0.89 | ALDH1A1 (0.42) | HTTCA12CA1CA2CA3 | |
| SCHEMBL31124627 | 0.87 | HTT (0.47) | HTTCDK1CA12CA1CA2 | |
| SCHEMBL10621991 | 0.85 | ALDH1A1 (0.42) | HTTCA12CA1CA2CA3 | |
| SCHEMBL8911310 | 0.83 | ALDH1A1 (0.38) | HTTCA12CA1CA2CA3 | |
| SCHEMBL12640416 | 0.81 | MAOB (0.41) | HTTKDM4ESMN1; SMN2MEN1KMT2A | |
| SCHEMBL23388953 | 0.79 | NAAA (0.42) | HTTCA2L3MBTL1 | |
| SCHEMBL9395608 | 0.77 | LMNA (0.46) | HTTCDK1POLBKDM4ESMN1; SMN2 | |
| SCHEMBL621824 | 0.77 | LMNA (0.52) | CA2KDM4EALDH1A1MAP2K1HSD17B10 | |
| SCHEMBL9180929 | 0.76 | LMNA (0.35) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4656682-A2 | RADIOPAQUE MULTI-ARMED POLYMERS AND COMPOSITIONS, SYSTEMS AND METHODS PERTAINING TO THE SAME | Boston Scientific Scimed, Inc. (US) | 2025-12-03 | — | — | EP | disclosed |
| EP-4021513-B1 | RADIOPAQUE MULTI-ARMED POLYMERS AND COMPOSITIONS, SYSTEMS AND METHODS PERTAINING TO THE SAME | BOSTON SCIENT SCIMED INC (US) | 2025-11-26 | — | — | EP | disclosed |
| US-20250243367-A1 | RADIOPAQUE MULTI-ARMED POLYMERS AND COMPOSITIONS, SYSTEMS AND METHODS PERTAINING TO THE SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-07-31 | — | — | US | disclosed |
| US-12297335-B2 | Radiopaque multi-armed polymers and compositions, systems and methods pertaining to the same | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-05-13 | — | — | US | disclosed |
| CN-114206984-A | Radiopaque, multi-armed polymers, and compositions, systems, and methods related thereto | 波士顿科学医学有限公司 | 2022-03-18 | — | — | CN | disclosed |
| US-20210062004-A1 | RADIOPAQUE MULTI-ARMED POLYMERS AND COMPOSITIONS, SYSTEMS AND METHODS PERTAINING TO THE SAME | BOSTON SCIENTIFIC SCIMED, INC. | 2021-03-04 | — | — | US | disclosed |
| EP-1131280-B1 | PREPARATION OF 5-AMINO-ISOPHTHALAMIDES | AMERSHAM HEALTH AS (NO) | 2004-08-11 | — | — | EP | disclosed |
| US-6441235-B1 | DI-LOWER-ALKYL-5-NITROISOPHTHALATE REACTS WITH A DIHYDROXY-MONOALKYLAMINE IN THE PRESENCE OF A BASIC CATALYST AND THEN CATALYLYTICALLY HYDROGENATED, WITHOUT ISOLATING THE 5-NITRO-N,N'-BIS(R)ISOPHTHALAMIDE INTERMEDIATE | AMERSHA, HEALTH AS (NO) | 2002-08-27 | — | — | US | disclosed |
| US-20020095053-A1 | Preparation of 5-amino-isophthalamides | GE HEALTHCARE AS (NO) | 2002-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020095053-A1 | Preparation of 5-amino-isophthalamides | DNPH1, DDAH1, DOHH | HTT 1201/4885CDK1 4310/4885CA12 2644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.